Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Puma Biotechnology Inc
Swot
Puma Biotechnology Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Puma Biotechnology Inc has 34 Strengths, 4 Weaknesses, 5 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(34)
Weakness
(4)
Opportunity
(5)
Threats
(0)
Others
(2)
Positive Breakout First Resistance ( LTP > R1)
High DVM Mid and Small Caps (subscription)
Stocks in Buy Zone with High Momentum Score Last Month
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE
Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV
Companies with 10% increase in share price over three months, with rising net profit growth
High Normalized Momentum Score
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over 1 Month
Relative Outperformance versus Industry over the Quarter (3 Months)
Relative Outperformance versus Industry over 1 Year
Higher DVM Stocks Among Midcaps and Largecaps
Big Gainers in Share Price with Good Net Profit Growth
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Month
Affordable Stocks - Stocks with Good Trendlyne Valuation Score
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Companies with reducing Debt
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Stock gained more than 20% in one month
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Positive Breakout (LTP > R1)
Top Gainers
Stock with Low PE (PE < = 10)
RSI indicating price strength
Negative to Positive growth in Sales and Profit with Strong Price momentum
Volume Shockers
High Volume, High Gain
Highest Recovery from 52 Week Low
Stocks Outperforming their Industry Price Change in the Quarter
MACD Crossover Below Signal Line
PE higher than Industry PE
MACD crossed below signal line previous end of day
Declining Net Cash Flow : Companies not able to generate net cash
Mutual Funds Increased Shareholding in Past Month
Institutions increasing their shareholding
Mutual Funds Increased Shareholding over the Past Two Months
MFs increased their shareholding last quarter
Mf buying for 2 months
Strong Performers - High DVM Stocks
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks